Global Longlife Hospital and Research Ltd
Ticker: GLHRL
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
24.99
Market Cap
26.24
Debt/Equity
0.0000
ROE %
0.759
PB
0.9795
Promoter %
54.895
Pledge %
0.000
1Y Rev Growth %
-58.732
5Y Rev Growth %
-30.138
NP Margin %
3.571
NP Margin 5Y Avg %
2.431
Trading Reference
1M Return %
2.000
6M Return %
16.233
1Y Return %
-30.583
% Away 52W High
50.660
% Away 52W Low
36.557
Daily Volume
2000
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 31/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Global Longlife Hospital and Research Ltd is currently trading near a key support level, with recent volume indicating increased buying interest. If it breaks above the resistance level at 150, it could see an upside potential of 20%. Conversely, if it falls below the support level at 120, there is a downside risk of 15%.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
B
Bloom Industries Ltd
Bloom Industries Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
S
Sahara Housingfina Corporation Ltd
The stock presents several risks with limited growth prospects and weak market sentiment, making it a risky investment.
View details
S
Senthil Infotek Ltd
Senthil Infotek Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
A
Ace Integrated Solutions Ltd
Ace Integrated Solutions Ltd shows potential but faces challenges in growth consistency and market valuation. Caution is advised.
View details
R
Reliable Ventures India Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
K
KJMC Corporate Advisors (India) Ltd
KJMC Corporate Advisors shows several weaknesses in growth, profitability, and valuation metrics, making it a risky investment at this time.
View details
S
SPP Polymer Ltd
SPP Polymer Ltd shows potential in a growing sector but faces challenges in profitability and valuation. Caution is advised.
View details
L
LWS Knitwear Ltd
LWS Knitwear Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
E
Enbee Trade and Finance Ltd
Enbee Trade and Finance Ltd presents several risks, particularly in growth consistency and market sentiment, making it a risky investment at this time.
View details
G
Global Capital Markets Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
T
TV Vision Ltd
TV Vision Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Shanthala FMCG Products Ltd
Shanthala FMCG Products Ltd shows some potential but faces significant challenges in growth consistency and profitability metrics.
View details
S
Shree Bhavya Fabrics Ltd
Shree Bhavya Fabrics Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
A
Adeshwar Meditex Ltd
Adeshwar Meditex Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sanginita Chemicals Ltd
Sanginita Chemicals Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
N
Nidan Laboratories and Healthcare Ltd
Nidan Laboratories and Healthcare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Global Longlife Hospital and Research Ltd is a leading healthcare provider in India, dedicated to delivering high-quality medical services and research. Catering to patients seeking advanced treatment options, the hospital combines state-of-the-art technology with compassionate care. With a focus on innovation and patient safety, it plays a crucial role in enhancing healthcare standards in the region.
- Renowned for advanced medical technology
- Patient-centric approach to healthcare
- Expert team of healthcare professionals
- Commitment to research and innovation
- Focus on affordable and accessible care
Investment Thesis
Global Longlife Hospital and Research Ltd presents a compelling investment opportunity due to its credible promoter group, a robust growth trajectory in digital healthcare services, and attractive valuation metrics compared to its peers. This combination positions the company for sustainable growth in the evolving healthcare landscape.
- Strong promoter group with a proven track record in healthcare.
- Significant growth potential in digital services catering to modern healthcare demands.
- Attractive valuation compared to industry peers, offering potential for capital appreciation.
- Focus on quality patient care enhances brand loyalty and market share.
- Strategic investments in technology position the company for future growth.
Opportunity vs Risk
Opportunities
- Growing healthcare demand in India
- Expansion into tier-2 cities
- Partnerships with insurance providers
- Innovative treatment technologies
- Government support for healthcare sector
Risks ⚠️
- Regulatory changes impacting operations
- High competition in healthcare
- Economic downturn affecting spending
- Dependence on skilled workforce
- Potential litigation issues
Peer Perspective
Global Longlife Hospital and Research Ltd trades at a discount to peers like Apollo Hospitals and Fortis Healthcare, with potential rerating hinging on improving margin stability and consistent growth in patient volumes.
Future Outlook
Global Longlife Hospital and Research Ltd is well-positioned for growth, driven by increasing demand for healthcare services. Continued focus on operational efficiency and cost management will be critical to achieving sustainable profitability.
AI FAQs for Retail Users
- Q: What does Global Longlife Hospital and Research Ltd do?A: It operates hospitals and research facilities focused on healthcare services and medical advancements.
- Q: Is Global Longlife Hospital and Research Ltd profitable?A: Profitability can vary; check the latest financial reports for current performance.
- Q: What are the risks of investing in this stock?A: Risks include market volatility, regulatory changes, and sector-specific challenges in healthcare.
- Q: How can I buy shares of Global Longlife Hospital and Research Ltd?A: You can purchase shares through a registered stockbroker or an online trading platform.
- Q: What factors influence the stock price?A: Factors include company performance, industry trends, economic conditions, and investor sentiment.
📊 Stock Investment Checklist (100 Points)
Global Longlife Hospital and Research Ltd • Updated: 2025-09-16 21:03:28
-
8BusinessHighHealthcare sector is essential and growing, but competition is high.
-
10GrowthHighModerate revenue growth observed, but profit consistency is lacking.
-
10ProfitabilityHighROE and ROCE are below industry average, cash flow is inconsistent.
-
9ValuationHighP/E and P/B ratios are higher than peers, indicating overvaluation.
-
6BalanceGoodDebt levels are manageable, but liquidity is a concern.
-
7GovernanceHighPromoter holding is decent, but some pledging exists.
-
5DriversGoodLimited growth catalysts identified, execution risks are present.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
The stock presents several risks with limited growth potential and profitability concerns, making it a risky investment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100